Listen to the full episode below:
Rob Orman, MD and Greg Moran, MD
When did UTI’s become so complex? The increasing frequency of extended spectrum beta lactamase (ESBL) bacteria has made treatment of cystitis confusing and challenging. Infectious disease specialist Greg Moran breaks down ESBL treatment options.
Pullukcu, Husnu, et al. “Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.” International journal of antimicrobial agents 29.1 (2007): 62-65.
Neuner, Elizabeth A., et al. “Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms.” Antimicrobial agents and chemotherapy 56.11 (2012): 5744-5748.